Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy
Publication date:
2018
Publisher version:
Citación:
Journal of Medicinal Chemistry, 61(15), p. 6518-6545 (2018); doi:10.1021/acs.jmedchem.7b01926
Descripción física:
p. 6518-6545
ISSN:
Patrocinado por:
Foundation for Applied Medical Research (FIMA); Fundacion Fuentes Dutor; Ministerio de Economia y Competitividad; Instituto de Salud Carlos III (FEDER funds) [PI10/01691, PI13/00862, PI13/01469, PI14/01867, PI16/02024, PI17/00701, RTICC RD12/0036/0068, CIBERONC (GB16/12/00489)]; ERA NET programs TRANSCAN-2 JTC EPICA by the "Torres Quevedo" Subprogram [PTQ-11-04777, PTQ-14-07320 I.D.M.]; Fundaci La Marato de TV3 [20132130-31-32]; Gobierno de Navarra [40/2016, PT053/2016, PT027/2017]; FSE (Inncorpora-Torres Quevedo grant); Plan Nacional de I+D+I 2013-2016/FEDER [PI15/00892]; Asturias Regional Government [GRUPIN14-052]; IUOPA-Obra Social Liberbank-Cajastur; University of Navarra (Pamplona, Spain); Asociacion de Amigos of University of Navarra
Collections
- Artículos [37542]
Files in this item
Métricas
Compartir
